Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Iridex Corp (IRIX)

Iridex Corp (IRIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Iridex Corporation Announces Landmark Study on MicroPulse Transscleral Laser Therapy for Glaucoma Treatment

Iridex announces a peer-reviewed study confirming MicroPulse TLT's effectiveness and safety in glaucoma treatment over five years.Quiver AI SummaryIridex Corporation announced the publication of a significant...

IRIX : 1.6400 (-4.09%)
Iridex Announces Milestone Five-Year Study Confirms the Long-Term Effectiveness and Safety of MicroPulse Transscleral Cyclophotocoagulation for Glaucoma Management

IRIX : 1.6400 (-4.09%)
Iridex Corporation Confirms Adoption of Local Coverage Determination L37531 for Micro-Invasive Glaucoma Surgery

Iridex confirms effective adoption of LCD L37531, enhancing reimbursement for its laser glaucoma treatments.Quiver AI SummaryIridex Corporation announced that the Local Coverage Determination (LCD) L37531...

IRIX : 1.6400 (-4.09%)
Iridex Comments on Changing Glaucoma Reimbursement Landscape

IRIX : 1.6400 (-4.09%)
Iridex: Q3 Earnings Snapshot

Iridex: Q3 Earnings Snapshot

IRIX : 1.6400 (-4.09%)
Iridex Reports Third Quarter 2024 Financial Results

IRIX : 1.6400 (-4.09%)
Iridex to Report Third Quarter 2024 Financial Results on November 12, 2024

IRIX : 1.6400 (-4.09%)
RMTI Stock Rises 138% in Q3: What Should You Do Ahead of Earnings?

Rockwell Medical RMTI is scheduled to report third-quarter 2024 results on Nov. 11, before the opening bell.In the last reported quarter, the company’s adjusted earnings of 1 cent exceeded the Zacks...

RMTI : 2.08 (+1.46%)
IRIX : 1.6400 (-4.09%)
EDAP : 2.19 (-0.23%)
Rockwell Medical on Expansion Spree: Should You Buy the Stock Now?

Good times continue for Rockwell Medical RMTI stock. Back-to-back big announcements over the recent months, like the company’s new launches for home hemodialysis, a multi-million-dollar distribution...

RMTI : 2.08 (+1.46%)
IRIX : 1.6400 (-4.09%)
EDAP : 2.19 (-0.23%)
Iridex Appoints Patrick Mercer as Chief Executive Officer

IRIX : 1.6400 (-4.09%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar